Literature DB >> 8050476

Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.

P Chatelain1, P Dewinkeleer, P Beaufort, L Meysmans, M Clinet.   

Abstract

SR 33805 is a representative of a new class of compounds (indole sulfone) that inhibits L-type Ca2+ channels. [3H]SR 33805 has been shown to bind with a high affinity (Kd approximately 20 pM calculated from saturation isotherms and association/dissociation kinetics) to a single site in a purified preparation of rat cardiac sarcolemmal membranes. The binding was found to be saturable and reversible. The maximal binding capacity was in approximately 1:1 stoichiometry with that of other Ca2+ channel antagonists. Various cations (Na+, Ca2+, Cd2+, and La3+) were shown to inhibit specific [3H]SR 33805 binding, with La3+ being the most potent. Using a range of receptor or channel ligands (including omega-conotoxin and Na+ and K+ channel modulators), only the L-type Ca2+ channel antagonists were found to displace [3H]SR 33805. However, dihydropyridines, phenylalkylamines, benzothiazepines, and diphenyl-butylpiperidines were found to inhibit [3H]SR 33805 in a non-competitive manner as demonstrated by displacement experiments in addition to dissociation kinetics. In contrast, the interaction of SR 33805 with fantofarone has been found to be competitive. Binding of [3H]SR 33805 (and [3H]fantofarone) is entropy driven as opposed to that of the [3H]nitrendipine which is enthalpy driven. From these results we suggest that SR 33805 binds with a high affinity to a unique site on the L-type Ca2+ channel found in rat cardiac sarcolemmal membranes. This site is equivalent to that of fantofarone and in allosteric interaction with that of the dihydropyridines, phenylalkylamines and benzothiazepines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050476     DOI: 10.1016/0922-4106(94)90166-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Alteration of the [Ca(2+)](i)-force relationship during the vasorelaxation induced by a Ca(2+) channel blocker SR33805 in the porcine coronary artery.

Authors:  S Ieiri; K Hirano; J Nishimura; S Suita; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Beneficial effects of SR33805 in failing myocardium.

Authors:  Younss Ait Mou; Attila Toth; Cécile Cassan; Daniel Czuriga; Pieter P de Tombe; Zoltan Papp; Alain Lacampagne; Olivier Cazorla
Journal:  Cardiovasc Res       Date:  2011-04-04       Impact factor: 10.787

3.  SR33805, a Ca2+ antagonist with length-dependent Ca2+ -sensitizing properties in cardiac myocytes.

Authors:  Olivier Cazorla; Alain Lacampagne; Jeremy Fauconnier; Guy Vassort
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.